ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

Leter: Payers Must Determine Appropriate Therapies

July 19, 1996

Researchers Discover Bacteria Common in Colon Cancer Tissue

October 28, 2011

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982

Center Bitter Over NCI’s Reacting To IOM report, Core grant Losses, Program Staff Cuts

June 30, 1989